Oireachtas Joint and Select Committees
Wednesday, 6 March 2019
Joint Oireachtas Committee on Health
National Medicines Strategy: Discussion
Dr. Kieran Harkin:
It was envisaged that BeNeLuxA and Valletta, an organisation of southern European countries, would perform that function and it has been disappointing that they have not done that. In BeNeLuxA, one country decided to approve Spinraza and the other not. It is still fairly early days, it is a difficult process and the hope still rests with the development of groups such as BeNeLuxA and Valletta.